1. Home
  2. EYPT vs NFBK Comparison

EYPT vs NFBK Comparison

Compare EYPT & NFBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EYPT
  • NFBK
  • Stock Information
  • Founded
  • EYPT 1987
  • NFBK 1887
  • Country
  • EYPT United States
  • NFBK United States
  • Employees
  • EYPT N/A
  • NFBK N/A
  • Industry
  • EYPT Biotechnology: Laboratory Analytical Instruments
  • NFBK Major Banks
  • Sector
  • EYPT Industrials
  • NFBK Finance
  • Exchange
  • EYPT Nasdaq
  • NFBK Nasdaq
  • Market Cap
  • EYPT 484.4M
  • NFBK 406.5M
  • IPO Year
  • EYPT 2005
  • NFBK 2007
  • Fundamental
  • Price
  • EYPT $8.25
  • NFBK $11.70
  • Analyst Decision
  • EYPT Strong Buy
  • NFBK Buy
  • Analyst Count
  • EYPT 8
  • NFBK 2
  • Target Price
  • EYPT $24.29
  • NFBK $13.00
  • AVG Volume (30 Days)
  • EYPT 895.1K
  • NFBK 162.9K
  • Earning Date
  • EYPT 05-07-2025
  • NFBK 07-23-2025
  • Dividend Yield
  • EYPT N/A
  • NFBK 4.45%
  • EPS Growth
  • EYPT N/A
  • NFBK 1.58
  • EPS
  • EYPT N/A
  • NFBK 0.76
  • Revenue
  • EYPT $56,042,000.00
  • NFBK $128,407,000.00
  • Revenue This Year
  • EYPT N/A
  • NFBK $10.59
  • Revenue Next Year
  • EYPT N/A
  • NFBK $15.58
  • P/E Ratio
  • EYPT N/A
  • NFBK $15.30
  • Revenue Growth
  • EYPT 12.04
  • NFBK N/A
  • 52 Week Low
  • EYPT $3.91
  • NFBK $6.98
  • 52 Week High
  • EYPT $13.99
  • NFBK $14.39
  • Technical
  • Relative Strength Index (RSI)
  • EYPT 72.87
  • NFBK 56.46
  • Support Level
  • EYPT $5.46
  • NFBK $11.18
  • Resistance Level
  • EYPT $8.36
  • NFBK $11.84
  • Average True Range (ATR)
  • EYPT 0.57
  • NFBK 0.37
  • MACD
  • EYPT 0.24
  • NFBK -0.04
  • Stochastic Oscillator
  • EYPT 96.21
  • NFBK 64.20

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.

About NFBK Northfield Bancorp Inc. (Delaware)

Northfield Bancorp Inc is the holding company for Northfield Bank. Its subsidiary provides banking services to individuals and corporate customers in Richmond and Kings Counties in New York, and Hunterdon, Mercer, Union and Middlesex counties in New Jersey. The bank attracts deposits and offers credit and other banking services.

Share on Social Networks: